Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg i...(tual results and developments to differm...),Health

Date:8/18/2008

tual results and developments to differ materially from that expressed or implied by these forward-looking statements. These factors include, among other things, exchange rate fluctuations, the risk that research and development will not yield new products that achieve commercial success, the impact of competition, price controls and price reductions, the risk of loss or expiration of patents or trade marks, difficulties of obtaining and maintaining governmental approvals for products, the risk of substantial product liability claims, exposure to environmental liability.

'/>"/>

SOURCE Actavis Group Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. Harvard Business School Publishes a Case Study on Robert Wessman and Actavis
2. Actavis Extends Portfolio With Four New Products in the U.S.
3. Actavis Confirms its Patent Challenge of Kings Avinza(R)
4. Actavis Launches Amlodipine Tablets in the U.S.
5. Actavis Launches Carvedilol Tablets in the U.S.
6. New probe to detect skin cancer receives more funding for clinical trials
7. NUCRYST Receives Deficiency Notice from NASDAQ
8. Dr. Ajrawats Air-Pulse Autonomic Meditation Therapy, a Revolutionary, Scientific, Meditation Therapy, Receives Patent Trademark
9. PathNet Esoteric Laboratory Institute Main Laboratory Receives Accreditation From College of American Pathologists
10. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
11. Morris Animal Foundation Receives $1 Million Donation From Hills for Cat Health Research - Cat Lovers Have Reason to Celebrate